FEATURED, Research, Metastatic breast cancer
STUDIES SUGGEST THE PRESENCE OF ESR1 MUTATION IMPACTS CHOICE OF THERAPY IN ER+ METASTATIC BREAST CANCER
Presence of mutant ESR1 may stimulate endocrine resistance Hormonal therapy benefits approximately 30% of patients with metastatic breast cancer. By adding CDK ...
